Description: Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
Home Page: www.pulsebiosciences.com
3957 Point Eden Way
Hayward,
CA
94545
United States
Phone:
510 906 4600
Officers
| Name | Title |
|---|---|
| Mr. Robert W. Duggan | Executive Co-Chairman |
| Mr. Darrin R. Uecker | CTO & Director |
| Mr. Mitchell E. Levinson | Chief Strategy Officer |
| Mr. Kevin P. Danahy | Chief Commercial Officer |
| Mr. Burke T. Barrett | President, CEO & Director |
| Mr. Edison Manuel | Vice President of Operations |
| Dr. Richard Nuccitelli Ph.D. | Chief Science Officer |
| Mr. Kenneth B. Stratton Esq., J.D. | General Counsel & Corporate Secretary |
| Ms. Patty Perla | Vice President of Human Resources |
| Mr. David Danitz | Senior Vice President of Engineering |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 14.4008 |
| Price-to-Sales TTM: | 54.2191 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 56 |